chr19-3192652-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020170.4(NCLN):c.367G>A(p.Val123Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000424 in 1,556,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020170.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCLN | NM_020170.4 | c.367G>A | p.Val123Ile | missense_variant | 2/15 | ENST00000246117.9 | NP_064555.2 | |
NCLN | NM_001321463.2 | c.367G>A | p.Val123Ile | missense_variant | 2/15 | NP_001308392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCLN | ENST00000246117.9 | c.367G>A | p.Val123Ile | missense_variant | 2/15 | 1 | NM_020170.4 | ENSP00000246117.3 | ||
NCLN | ENST00000590671.5 | c.145G>A | p.Val49Ile | missense_variant | 2/15 | 2 | ENSP00000466678.1 | |||
NCLN | ENST00000588428.5 | c.185-3531G>A | intron_variant | 5 | ENSP00000467011.1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000419 AC: 8AN: 191044Hom.: 0 AF XY: 0.0000468 AC XY: 5AN XY: 106828
GnomAD4 exome AF: 0.0000313 AC: 44AN: 1404058Hom.: 0 Cov.: 32 AF XY: 0.0000346 AC XY: 24AN XY: 693364
GnomAD4 genome AF: 0.000144 AC: 22AN: 152358Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 11, 2023 | The c.367G>A (p.V123I) alteration is located in exon 2 (coding exon 2) of the NCLN gene. This alteration results from a G to A substitution at nucleotide position 367, causing the valine (V) at amino acid position 123 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at